Department of Neurosurgery, University of Virginia, Charlottesville, VA 22908, USA.
J Neurosurg. 2013 Aug;119(2):463-71. doi: 10.3171/2013.4.JNS122195. Epub 2013 May 24.
Gamma Knife surgery (GKS) is a safe and effective treatment for patients with small to moderately sized vestibular schwannomas (VSs). Reports of stereotactic radiosurgery for large VSs have demonstrated worse tumor control and preservation of neurological function. The authors endeavored to assess the effect of size of VSs treated using GKS.
This study was a retrospective comparison of 24 patients with large VSs (> 3 cm in maximum diameter) treated with GKS compared with 49 small VSs (≤ 3 cm) matched for age, sex, radiosurgical margin and maximal doses, length of follow-up, and indication.
Actuarial tumor progression-free survival (PFS) for the large VS cohort was 95.2% and 81.8% at 3 and 5 years, respectively, compared with 97% and 90% for small VSs (p = 0.009). Overall clinical outcome was better in small VSs compared with large VSs (p < 0.001). Patients with small VSs presenting with House-Brackmann Grade I (good facial function) had better neurological outcomes compared with patients with large VSs (p = 0.003). Treatment failure occurred in 6 patients with large VSs; 3 each were treated with resection or repeat GKS. Treatment failure did not occur in the small VS group. Two patients in the large VS group required ventriculoperitoneal shunt placement. Univariate analysis did not identify any predictors of treatment failure among the large VS cohort.
Patients with large VSs treated using GKS had shorter PFS and worse clinical outcomes compared with age-, sex-, and indication-matched patients with small VSs. Nevertheless, GKS has efficacy for some patients with large VSs and represents a reasonable treatment option for selected patients.
伽玛刀手术(GKS)是治疗小至中等大小前庭神经鞘瘤(VSs)患者的安全有效方法。对于大型 VSs 的立体定向放射外科治疗报告显示肿瘤控制和神经功能保护较差。作者努力评估使用 GKS 治疗的 VSs 大小的影响。
本研究是对 24 例大型 VSs(最大直径> 3cm)患者使用 GKS 治疗与 49 例小 VSs(≤3cm)的回顾性比较,这些患者在年龄、性别、放射外科边缘和最大剂量、随访时间和适应症方面相匹配。
大 VS 队列的肿瘤无进展生存(PFS)的实际生存率分别为 3 年和 5 年时的 95.2%和 81.8%,而小 VSs 为 97%和 90%(p=0.009)。与大 VSs 相比,小 VSs 的总体临床结局更好(p<0.001)。患有 House-Brackmann 分级 I(良好的面神经功能)的小 VSs 患者的神经功能结局优于大 VSs 患者(p=0.003)。6 例大 VSs 患者发生治疗失败;3 例分别接受了切除或重复 GKS 治疗。小 VS 组未发生治疗失败。大 VS 组中有 2 例患者需要放置脑室-腹腔分流术。单因素分析未在大 VS 队列中确定任何治疗失败的预测因素。
与年龄、性别和适应症相匹配的小 VSs 患者相比,使用 GKS 治疗的大 VSs 患者的 PFS 更短,临床结局更差。尽管如此,GKS 对一些大 VSs 患者有效,是一些患者的合理治疗选择。